Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA Office of Generic Drugs

This article was originally published in The Tan Sheet

Executive Summary

FDA Office of Generic Drugs: Acting Director Douglas Sporn will become deputy director of the new Office of Pharmaceutical Science under Roger Williams, MD, who will head the office as well as serve as deputy center director for pharmaceutical science. Sporn will oversee the establishment of the Office of New Drug Chemistry. A replacement for Sporn, who leaves OGD in August, has not been announced. FDA is recruiting for a permanent director for OGD both inside and outside the agency....
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084047

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel